Merck Can't Duck Jury Award In Fosamax Bellwether Suit
A New York federal judge on Monday denied Merck & Co. Inc.'s attempt to wipe out a $285,000 plaintiff verdict in a bellwether trial in multidistrict litigation claiming the bone drug...To view the full article, register now.
Already a subscriber? Click here to view full article